[
  {
    "": 0,
    "Gene name": "GNAS",
    "Genomic Position": "20:57427769-57486247(+)",
    "CDS Mutation": "R201H",
    "AA Mutation": "p.R201H",
    "Disease": "Thyroid Gland Follicular Carcinoma",
    "therapy_rank": 4,
    "Response to Drug": "Sensitivity",
    "Therapies": "Radioactive Iodine",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:26788326"
  },
  {
    "": 1,
    "Gene name": "BRAF",
    "Genomic Position": "7:140434279-140624564(-)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "thyroid / carcinoma / NS",
    "therapy_rank": 1,
    "Response to Drug": "Sensitivity",
    "Therapies": "Pertuzumab,Vemurafenib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:29320312"
  },
  {
    "": 2,
    "Gene name": "BRAF",
    "Genomic Position": "7:140434279-140624564(-)",
    "CDS Mutation": "c.1799T>A",
    "AA Mutation": "p.V600E",
    "Disease": "Thyroid Gland Anaplastic Carcinoma",
    "therapy_rank": 2,
    "Response to Drug": "Sensitivity",
    "Therapies": "Pertuzumab,Vemurafenib",
    "Description": "",
    "rs value": 113488022,
    "pmid": "PubMed:29320312"
  },
  {
    "": 3,
    "Gene name": "BRAF",
    "Genomic Position": "7:140434279-140624564(-)",
    "CDS Mutation": "c.1799T>A",
    "AA Mutation": "p.V600E",
    "Disease": "thyroid / carcinoma / NS",
    "therapy_rank": 2,
    "Response to Drug": "Sensitivity",
    "Therapies": "Pertuzumab,Vemurafenib",
    "Description": "",
    "rs value": 113488022,
    "pmid": "PubMed:29320312"
  },
  {
    "": 4,
    "Gene name": "BRAF",
    "Genomic Position": "7:140434279-140624564(-)",
    "CDS Mutation": "V600E/K",
    "AA Mutation": "p.V600E/K",
    "Disease": "thyroid / carcinoma / anaplastic carcinoma",
    "therapy_rank": 2,
    "Response to Drug": "Sensitivity",
    "Therapies": "Pertuzumab,Vemurafenib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:29320312"
  },
  {
    "": 5,
    "Gene name": "BRAF",
    "Genomic Position": "7:140434279-140624564(-)",
    "CDS Mutation": "c.1799T>A",
    "AA Mutation": "p.V600E",
    "Disease": "thyroid / carcinoma / anaplastic carcinoma",
    "therapy_rank": 2,
    "Response to Drug": "Sensitivity",
    "Therapies": "Pertuzumab,Vemurafenib",
    "Description": "",
    "rs value": 113488022,
    "pmid": "PubMed:29320312"
  },
  {
    "": 6,
    "Gene name": "BRAF",
    "Genomic Position": "7:140434279-140624564(-)",
    "CDS Mutation": "c.1799T>A",
    "AA Mutation": "p.V600E",
    "Disease": "thyroid / carcinoma / papillary carcinoma",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Pertuzumab,Vemurafenib",
    "Description": "",
    "rs value": 113488022,
    "pmid": "PubMed:29320312"
  },
  {
    "": 7,
    "Gene name": "BRAF",
    "Genomic Position": "7:140434279-140624564(-)",
    "CDS Mutation": "c.1799T>A",
    "AA Mutation": "p.V600E",
    "Disease": "Thyroid Gland Papillary Carcinoma",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Pertuzumab,Vemurafenib",
    "Description": "",
    "rs value": 113488022,
    "pmid": "PubMed:29320312"
  },
  {
    "": 8,
    "Gene name": "BRAF",
    "Genomic Position": "7:140434279-140624564(-)",
    "CDS Mutation": "c.1799T>A",
    "AA Mutation": "p.V600E",
    "Disease": "Thyroid Gland Anaplastic Carcinoma",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Pertuzumab,Vemurafenib",
    "Description": "",
    "rs value": 113488022,
    "pmid": "PubMed:29320312"
  },
  {
    "": 9,
    "Gene name": "BRAF",
    "Genomic Position": "7:140434279-140624564(-)",
    "CDS Mutation": "V600E/M",
    "AA Mutation": "p.V600E/M",
    "Disease": "thyroid / carcinoma / NS",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Pertuzumab,Vemurafenib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:29320312"
  },
  {
    "": 10,
    "Gene name": "BRAF",
    "Genomic Position": "7:140434279-140624564(-)",
    "CDS Mutation": "c.1799T>A",
    "AA Mutation": "p.V600E",
    "Disease": "thyroid / carcinoma / anaplastic carcinoma",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Pertuzumab,Vemurafenib",
    "Description": "",
    "rs value": 113488022,
    "pmid": "PubMed:29320312"
  },
  {
    "": 11,
    "Gene name": "BRAF",
    "Genomic Position": "7:140434279-140624564(-)",
    "CDS Mutation": "c.1798delinsTACA",
    "AA Mutation": "p.V600",
    "Disease": "thyroid / carcinoma / anaplastic carcinoma",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Pertuzumab,Vemurafenib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:29320312"
  },
  {
    "": 12,
    "Gene name": "BRAF",
    "Genomic Position": "7:140434279-140624564(-)",
    "CDS Mutation": "c.1799T>A",
    "AA Mutation": "p.V600E",
    "Disease": "thyroid / carcinoma / NS",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Pertuzumab,Vemurafenib",
    "Description": "",
    "rs value": 113488022,
    "pmid": "PubMed:29320312"
  },
  {
    "": 13,
    "Gene name": "BRAF",
    "Genomic Position": "7:140434279-140624564(-)",
    "CDS Mutation": "c.1799T>A",
    "AA Mutation": "p.V600E",
    "Disease": "Thyroid Gland Papillary Carcinoma",
    "therapy_rank": 4,
    "Response to Drug": "Sensitivity",
    "Therapies": "Pertuzumab,Vemurafenib",
    "Description": "",
    "rs value": 113488022,
    "pmid": "PubMed:29320312"
  },
  {
    "": 14,
    "Gene name": "BRAF",
    "Genomic Position": "7:140434279-140624564(-)",
    "CDS Mutation": "c.1799T>A",
    "AA Mutation": "p.V600E",
    "Disease": "Thyroid Gland Anaplastic Carcinoma",
    "therapy_rank": 4,
    "Response to Drug": "Sensitivity",
    "Therapies": "Pertuzumab,Vemurafenib",
    "Description": "",
    "rs value": 113488022,
    "pmid": "PubMed:29320312"
  },
  {
    "": 15,
    "Gene name": "ALK",
    "Genomic Position": "2:29415640-30144432(-)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "thyroid / carcinoma / anaplastic carcinoma",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Crizotinib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:24687827"
  },
  {
    "": 16,
    "Gene name": "ALK",
    "Genomic Position": "2:29415640-30144432(-)",
    "CDS Mutation": "Fusion",
    "AA Mutation": "Fusion",
    "Disease": "Thyroid Gland Anaplastic Carcinoma",
    "therapy_rank": 4,
    "Response to Drug": "Sensitivity",
    "Therapies": "Crizotinib",
    "Description": "",
    "rs value": "",
    "pmid": "PubMed:24687827"
  },
  {
    "": 17,
    "Gene name": "HRAS",
    "Genomic Position": "11:532243-535550(-)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "thyroid / carcinoma / NS",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Tipifarnib",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT02383927"
  },
  {
    "": 18,
    "Gene name": "KRAS",
    "Genomic Position": "12:25362365-25403737(-)",
    "CDS Mutation": "G12_or_HRAS_G13_or_HRAS_Q61_or_KRAS_G12_or_KRAS_G13_or_KRAS_Q61_or_NRAS_G12_or_NRAS_G13_or_NRAS_Q61",
    "AA Mutation": "p.G12_or_HRAS_G13_or_HRAS_Q61_or_KRAS_G12_or_KRAS_G13_or_KRAS_Q61_or_NRAS_G12_or_NRAS_G13_or_NRAS_Q61",
    "Disease": "thyroid / carcinoma / NS",
    "therapy_rank": 2,
    "Response to Drug": "Sensitivity",
    "Therapies": "Radioiodine + Trametinib",
    "Description": "",
    "rs value": "",
    "pmid": "DOI:NCT02152995"
  },
  {
    "": 19,
    "Gene name": "NRAS",
    "Genomic Position": "1:115247090-115259515(-)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "thyroid / carcinoma / NS",
    "therapy_rank": 1,
    "Response to Drug": "Sensitivity",
    "Therapies": "Radioiodine + Selumetinib",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT01843062"
  },
  {
    "": 20,
    "Gene name": "NRAS",
    "Genomic Position": "1:115247090-115259515(-)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "thyroid / carcinoma / NS",
    "therapy_rank": 2,
    "Response to Drug": "Sensitivity",
    "Therapies": "Radioiodine + Selumetinib",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT01843062"
  },
  {
    "": 21,
    "Gene name": "NRAS",
    "Genomic Position": "1:115247090-115259515(-)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "thyroid / carcinoma / NS",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Radioiodine + Selumetinib",
    "Description": "",
    "rs value": "",
    "pmid": "ClinicalTrials.gov:NCT01843062"
  },
  {
    "": 22,
    "Gene name": "TP53",
    "Genomic Position": "17:7571720-7590856(-)",
    "CDS Mutation": "unspecified",
    "AA Mutation": "unspecified",
    "Disease": "thyroid / carcinoma / anaplastic carcinoma",
    "therapy_rank": 3,
    "Response to Drug": "Sensitivity",
    "Therapies": "Cisplatin + Crolibulin",
    "Description": "",
    "rs value": "",
    "pmid": "DOI:NCT01240590"
  }
]